Advertisement
Advertisement
ORGO
Organogenesis Holdings Inc. Class A Common Stock
3.90
USDSponsored
-0.15
-3.83%
Feb 04, 15:59 UTC -5
Closed
After-Market
3.93
+0.04
+0.90%
ORGO Earnings Reports
Positive Surprise Ratio
ORGO beat 19 of 27 last estimates.
70%
Next Report
Date of Next Report
Feb 26, 2026
Estimate for Q4 25 (Revenue/ EPS)
$176.15M
/$0.21
Implied change from Q3 25 (Revenue/ EPS)
+16.76%
/+40.00%
Implied change from Q4 24 (Revenue/ EPS)
+39.08%
/+250.00%
Organogenesis Holdings Inc. Class A Common Stock earnings per share and revenue
On Nov 06, 2025, ORGO reported earnings of 0.15 USD per share (EPS) for Q3 25, beating the estimate of 0.05 USD, resulting in a 167.38% surprise. Revenue reached 150.86 million, compared to an expected 136.78 million, with a 10.30% difference. The market reacted with a +44.73% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of 0.21 USD, with revenue projected to reach 176.15 million USD, implying an increase of 40.00% EPS, and increase of 16.76% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
What were Organogenesis Holdings Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Organogenesis Holdings Inc. Class A Common Stock reported EPS of $0.15, beating estimates by 167.38%, and revenue of $150.86M, 10.3% above expectations.
How did the market react to Organogenesis Holdings Inc. Class A Common Stock's Q3 2025 earnings?
The stock price moved up 44.73%, changed from $3.89 before the earnings release to $5.63 the day after.
When is Organogenesis Holdings Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Feb 26, 2026.
What are the forecasts for Organogenesis Holdings Inc. Class A Common Stock's next earnings report?
Based on 4
analysts, Organogenesis Holdings Inc. Class A Common Stock is expected to report EPS of $0.21 and revenue of $176.15M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement